322 related articles for article (PubMed ID: 19349317)
1. High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus.
Drew BG; Duffy SJ; Formosa MF; Natoli AK; Henstridge DC; Penfold SA; Thomas WG; Mukhamedova N; de Courten B; Forbes JM; Yap FY; Kaye DM; van Hall G; Febbraio MA; Kemp BE; Sviridov D; Steinberg GR; Kingwell BA
Circulation; 2009 Apr; 119(15):2103-11. PubMed ID: 19349317
[TBL] [Abstract][Full Text] [Related]
2. Reconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitus.
Drew BG; Carey AL; Natoli AK; Formosa MF; Vizi D; Reddy-Luthmoodoo M; Weir JM; Barlow CK; van Hall G; Meikle PJ; Duffy SJ; Kingwell BA
J Lipid Res; 2011 Mar; 52(3):572-81. PubMed ID: 21224289
[TBL] [Abstract][Full Text] [Related]
3. Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux.
Calkin AC; Drew BG; Ono A; Duffy SJ; Gordon MV; Schoenwaelder SM; Sviridov D; Cooper ME; Kingwell BA; Jackson SP
Circulation; 2009 Nov; 120(21):2095-104. PubMed ID: 19901191
[TBL] [Abstract][Full Text] [Related]
4. Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion.
Fryirs MA; Barter PJ; Appavoo M; Tuch BE; Tabet F; Heather AK; Rye KA
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1642-8. PubMed ID: 20466975
[TBL] [Abstract][Full Text] [Related]
5. HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis.
Di Bartolo BA; Cartland SP; Genner S; Manuneedhi Cholan P; Vellozzi M; Rye KA; Kavurma MM
J Diabetes Res; 2021; 2021():6668506. PubMed ID: 34095317
[TBL] [Abstract][Full Text] [Related]
6. Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages.
Tabet F; Lambert G; Cuesta Torres LF; Hou L; Sotirchos I; Touyz RM; Jenkins AJ; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1192-200. PubMed ID: 21330603
[TBL] [Abstract][Full Text] [Related]
7. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.
Patel S; Drew BG; Nakhla S; Duffy SJ; Murphy AJ; Barter PJ; Rye KA; Chin-Dusting J; Hoang A; Sviridov D; Celermajer DS; Kingwell BA
J Am Coll Cardiol; 2009 Mar; 53(11):962-71. PubMed ID: 19281927
[TBL] [Abstract][Full Text] [Related]
8. Flavonoids extracted from mulberry (Morus alba L.) leaf improve skeletal muscle mitochondrial function by activating AMPK in type 2 diabetes.
Meng Q; Qi X; Fu Y; Chen Q; Cheng P; Yu X; Sun X; Wu J; Li W; Zhang Q; Li Y; Wang A; Bian H
J Ethnopharmacol; 2020 Feb; 248():112326. PubMed ID: 31639486
[TBL] [Abstract][Full Text] [Related]
9. Glyceollin improves endoplasmic reticulum stress-induced insulin resistance through CaMKK-AMPK pathway in L6 myotubes.
Yoon EK; Jeong YT; Li X; Song-Cui ; Park DC; Kim YH; Kim YD; Chang HW; Lee SH; Hwang SL
J Nutr Biochem; 2013 Jun; 24(6):1053-61. PubMed ID: 23313043
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle insulin resistance associated with cholesterol-induced activation of macrophages is prevented by high density lipoprotein.
Carey AL; Siebel AL; Reddy-Luthmoodoo M; Natoli AK; D'Souza W; Meikle PJ; Sviridov D; Drew BG; Kingwell BA
PLoS One; 2013; 8(2):e56601. PubMed ID: 23437184
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A-I enhances insulin-dependent and insulin-independent glucose uptake by skeletal muscle.
Tang S; Tabet F; Cochran BJ; Cuesta Torres LF; Wu BJ; Barter PJ; Rye KA
Sci Rep; 2019 Feb; 9(1):1350. PubMed ID: 30718702
[TBL] [Abstract][Full Text] [Related]
12. Long-term high density lipoprotein infusion ameliorates metabolic phenotypes of diabetic db/db mice.
Zhang Q; Wan R; Guo R; Jin L; Liu Y; Li S
Diabetes Metab Res Rev; 2013 Feb; 29(2):130-8. PubMed ID: 23166092
[TBL] [Abstract][Full Text] [Related]
13. ApoA-1 improves glucose tolerance by increasing glucose uptake into heart and skeletal muscle independently of AMPKα
Fritzen AM; Domingo-Espín J; Lundsgaard AM; Kleinert M; Israelsen I; Carl CS; Nicolaisen TS; Kjøbsted R; Jeppesen JF; Wojtaszewski JFP; Lagerstedt JO; Kiens B
Mol Metab; 2020 May; 35():100949. PubMed ID: 32244181
[TBL] [Abstract][Full Text] [Related]
14. Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.
Xepapadaki E; Maulucci G; Constantinou C; Karavia EA; Zvintzou E; Daniel B; Sasson S; Kypreos KE
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1351-1360. PubMed ID: 30742993
[TBL] [Abstract][Full Text] [Related]
15. An adiponectin receptor agonist antibody stimulates glucose uptake and fatty-acid oxidation by activating AMP-activated protein kinase.
Jung D; Bucher F; Ryu S; Jeong J; Lee BY; Jeong Y; Kim MS; Oh YS; Baek MC; Yoon JH; Yea K
Cytokine; 2020 Feb; 126():154863. PubMed ID: 31629112
[TBL] [Abstract][Full Text] [Related]
16. Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle.
Dalla-Riva J; Stenkula KG; Petrlova J; Lagerstedt JO
J Lipid Res; 2013 May; 54(5):1275-82. PubMed ID: 23471027
[TBL] [Abstract][Full Text] [Related]
17. Antidiabetic activity of perylenequinonoid-rich extract from Shiraia bambusicola in KK-Ay mice with spontaneous type 2 diabetes mellitus.
Huang M; Zhao P; Xiong M; Zhou Q; Zheng S; Ma X; Xu C; Yang J; Yang X; Zhang TC
J Ethnopharmacol; 2016 Sep; 191():71-81. PubMed ID: 27286915
[TBL] [Abstract][Full Text] [Related]
18. In vivo PET imaging with [(18)F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes.
Cochran BJ; Ryder WJ; Parmar A; Tang S; Reilhac A; Arthur A; Charil A; Hamze H; Barter PJ; Kritharides L; Meikle SR; Gregoire MC; Rye KA
Diabetologia; 2016 Sep; 59(9):1977-84. PubMed ID: 27193916
[TBL] [Abstract][Full Text] [Related]
19. Fructated apolipoprotein A-I exacerbates cellular senescence in human umbilical vein endothelial cells accompanied by impaired insulin secretion activity and embryo toxicity.
Park KH; Kim JY; Choi I; Kim JR; Won KC; Cho KH
Biochem Cell Biol; 2016 Aug; 94(4):337-45. PubMed ID: 27487295
[TBL] [Abstract][Full Text] [Related]
20. Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.
Murphy AJ; Funt S; Gorman D; Tall AR; Wang N
Circ Res; 2013 Jun; 113(1):e1-e9. PubMed ID: 23613182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
